MiR-16 was first reported to be decreased in chronic lymphocytic leukemia (CLL) due to the deletion in chromosome 13q14 and inhibited apoptosis through targeting Bcl-2 [31]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.